David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 601 - 625 of 679

  1. Vlahov D, Astemborski J, Solomon L, Galai N, Basarab L, Nelson KE. Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S265-8.
  2. Alcabes P, Muñoz A, Vlahov D, Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol. 1994 Jan; 4(1):17-26.
  3. Nelson KE, Vlahov D, Galai N, Astemborski J, Solomon L. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S201-5.
  4. Caiaffa WT, Vlahov D, Antunes CM, de Oliveira HR, Diniz CR. Snake bite and antivenom complications in Belo Horizonte, Brazil. Trans R Soc Trop Med Hyg. 1994 Jan-Feb; 88(1):81-5.
  5. Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol. 1993 Dec 01; 138(11):909-22.
  6. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993 Sep 27; 153(18):2149-54.
  7. Watters JK, Jones TS, Shapshak P, McCoy CB, Flynn N, Gleghorn A, Vlahov D. Household bleach as disinfectant for use by injecting drug users. Lancet. 1993 Sep 18; 342(8873):742-3.
  8. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol. 1993 Sep; 9(5):566-9.
  9. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med. 1993 Aug 09; 153(15):1806-12.
  10. Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users. J Infect Dis. 1993 Aug; 168(2):327-31.
  11. Jason J, Solomon L, Celentano DD, Vlahov D. Potential use of mass media to reach urban intravenous drug users with AIDS prevention messages. Int J Addict. 1993 Jul; 28(9):837-51.
  12. Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson KE. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol. 1993 Apr 15; 137(8):892-8.
  13. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993 Apr 15; 71(11):955-8.
  14. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993 Apr; 88(4):517-26.
  15. Strickler HD, Blanchard JF, Vlahov D, Taylor E, Muñoz A, Nelson KE, Margolick JB. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. AIDS. 1993 Mar; 7(3):361-7.
  16. Willoughby SB, Vlahov D, Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. Am J Cardiol. 1993 Feb 15; 71(5):446-7.
  17. Alcabes P, Muñoz A, Vlahov D, Friedland GH. Incubation period of human immunodeficiency virus. Epidemiol Rev. 1993; 15(2):303-18.
  18. Concha M, Graham NM, Muñoz A, Vlahov D, Royal W, Updike M, Nance-Sproson T, Selnes OA, McArthur JC. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol. 1992 Dec 01; 136(11):1338-48.
  19. Galai N, Graham N, Chaisson R, Nelson KE, Vlahov D, Lewis J. Multidrug-resistant tuberculosis. N Engl J Med. 1992 Oct 15; 327(16):1172-3; author reply 1174.
  20. IJsselmuiden CB, Gaydos C, Feighner B, Novakoski WL, Serwadda D, Caris LH, Vlahov D, Comstock GW. Cancer of the pancreas and drinking water: a population-based case-control study in Washington County, Maryland. Am J Epidemiol. 1992 Oct 01; 136(7):836-42.
  21. Selnes OA, McArthur JC, Royal W, Updike ML, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology. 1992 Oct; 42(10):1924-30.
  22. Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992 Sep-Oct; 107(5):595-8.
  23. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickens R, Uhl GR. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 1992 Sep; 49(9):723-7.
  24. Smith MD, Celentano DD, Solomon L, Astemborski J, Vlahov D. Knowledge of therapeutics for human immunodeficiency virus infection among intravenous drug users. J Infect Dis. 1992 Sep; 166(3):685-6.
  25. Latkin CA, Vlahov D, Anthony JC, Cohn S, Mandell W, Nelson KE. Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland. Int J Addict. 1992 Jun; 27(6):717-25.